NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed)
About
This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). NCORP is designed to enhance generalizability and dissemination of clinical trial and other human subject research study results through accrual in a variety of community settings. The purpose of NCORP is to engage cancer patient populations, those at risk of cancer, and organizations in rigorous studies focused on cancer control, prevention, treatment and care delivery. NCORP is a community-based research network that: Designs and conducts clinical trials and other human subject studies for adults and children in cancer control, prevention, screening, and care delivery, as well as quality-of-life studies embedded within treatment trials; Enhances patient and provider access to treatment and imaging trials conducted under the National Clinical Trials Network (NCTN)NCORP will support the following components that will be individually awarded through the respective Request for Applications (RFAs) indicated below: NCORP Research Bases (UG1 Clinical Trials Required); NCORP Community Sites (UG1 Clinical Trials Not Allowed)(covered by this NOFO); andNCORP Academic Community Sites (UG1 Clinical Trials Not Allowed). The NCORP Community Sites is a healthcare system, a consortium of healthcare systems, or a consortia of community hospitals and/or oncology practices, public hospitals, and/or health care centers that can enhance the representative.
The NCI Community Oncology Research Program (NCORP) Community Sites grant is designed for healthcare systems, consortiums of healthcare systems, community hospitals, oncology practices, public hospitals, and health care centers that want to advance cancer research through community-based settings. This funding opportunity supports organizations in conducting rigorous human subject research studies focused on cancer control, prevention, screening, treatment, and care delivery without requiring participation in clinical trials at the community site level. NCORP Community Sites enhance the generalizability and dissemination of research results by engaging diverse cancer patient populations and those at risk of cancer in real-world healthcare environments. Organizations applying should be prepared to design and conduct non-clinical trial research studies, improve patient and provider access to quality-of-life research, and contribute to the broader National Cancer Institute's mission of cancer control and prevention. This program is ideal for community-based organizations seeking to participate in meaningful oncology research that reflects diverse patient populations and healthcare settings across the United States. The deadline for applications is September 18, 2026.
Funding Facts
● Applications openDeadline
September 18, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by cycle - consult official NOFO
Deadline
2026-09-18
Grant Type
federal
Application Cycle
Annual
Best For
Healthcare systems, community hospitals, oncology practices, public hospitals, and health care centers engaged in community-based cancer research
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Frequently Asked Questions
Who is eligible for NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed)?
Eligible applicants include healthcare systems, consortiums of healthcare systems, consortia of community hospitals and/or oncology practices, public hospitals, and/or health care centers. The organization must be able to enhance representative cancer patient populations and conduct non-clinical trial research studies. Foreign organizations and non-domestic components of U.S. organizations are not eligible. For detailed eligibility requirements, refer to Section III of the Notice of Funding Opportunity (NOFO) or visit the official NIH grants website.
How much funding does NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed) provide?
The specific funding amount varies and is not listed in the current funding cycle information. Applicants should consult the official NOFO and NIH grants website for detailed budget information, budget requirements, and any available funding ranges for this program cycle.
How do I apply for NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed)?
Applications are submitted through the NIH grants application system. Applicants should review the complete Notice of Funding Opportunity (NOFO) for detailed instructions, required documentation, and submission procedures. The application deadline is September 18, 2026. Visit grants.nih.gov and the National Cancer Institute website for the full NOFO, application portal, and technical assistance information.
What can NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed) funding be used for?
Funding supports the design and conduct of human subject research studies focused on cancer control, prevention, screening, treatment, and care delivery. This includes quality-of-life studies, research that enhances patient and provider access to treatment and imaging trials through the National Clinical Trials Network (NCTN), and studies that engage diverse cancer patient populations in community healthcare settings. Clinical trials at the community site level are not allowed under this specific NOFO.
Last updated: July 5, 2026